stockrowAllurion Technologies, Inc. (ALUR) vs Cytosorbents Corporation (CTSO)
- Allurion Technologies, Inc. ALUR 0.00 NaN
- Cytosorbents Corporation CTSO 4.75 +3.26%
Allurion Technologies, Inc. and Cytosorbents Corporation are both Medical Devices companies. Allurion Technologies, Inc. is the larger, with a market value of $16.7M against $14.5M — 1.2× the size. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −55.5%. Cytosorbents Corporation has the higher net margin (−48.9% vs −264.7%) and the lower return on invested capital (−66.9% vs 0.00%). Across the 15 metrics below, Cytosorbents Corporation leads on 11 and Allurion Technologies, Inc. on 4.
Valuation
Profitability
| Metric | ALUR | CTSO | Medical Devices median |
|---|---|---|---|
| Gross margin | 52.70% | 71.61% | 57.76% |
| Operating margin | (211.21%) | (34.74%) | (14.84%) |
| Net margin | (264.74%) | (48.94%) | (14.45%) |
| Free cash flow margin | (180.19%) | (25.32%) | (5.70%) |
| Return on equity | 45.16% | (336.17%) | (10.56%) |
| Return on assets | (127.26%) | (42.38%) | (17.26%) |
| Return on invested capital | 0.00% | (66.90%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack